Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Cancer Type:
Ovarian germ cell tumor
Stage/Subtype of Cancer:
stage II ovarian germ cell tumor
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
CINJ-3330
, NCT00161187
2.
Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-07044
, 07-044, NCT00470366
3.
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
06C.549
, NCT00437372
4.
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
45 and under
Sponsor:
Other
Protocol IDs:
2004-0079
, NCT00502892
5.
Randomized, Double Blind, Placebo-Controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
NYU 05-409
, NCT00821652
6.
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
TAMC 3H04
, NCT00160472
7.
Study of a Non-Cross-Resistant Conditioning Regimen Followed By Single or Tandem Autologous Peripheral Blood Stem Cell Transplantation in Patients With Germ Cell Tumors
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
10 to 69
Sponsor:
NCI
Protocol IDs:
UMN-2006LS032
, UMN-MT2005-21, UMN-0608M90586, NCT00432094
8.
TRIAD Burden of Illness Mucositis Study
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
No. 200509024
, NCT00336609
9.
Respiratory Tumor and Normal Tissue Motion
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2003-0962
, NCT00415675
10.
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Phase:
No phase specified
Type:
Health services research, Treatment
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
08-092
, NCT00746018
11.
Pilot Study of the Integration of Palliative Care With Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
Phase:
No phase specified
Type:
Health services research, Natural history/Epidemiology, Supportive care, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CHNMC-07007
, 07007, NCT00804258
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute